These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A century of progress in the therapy of leprosy. Karat AB; Ramanujam K Int J Lepr Other Mycobact Dis; 1973; 41(3):382-91. PubMed ID: 4130572 [No Abstract] [Full Text] [Related]
43. Patient compliance with dapsone administration in leprosy. Huikeshoven H Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150 [No Abstract] [Full Text] [Related]
44. Chemotherapy of leprosy. II. Compounds structurally related to 4, 4'-diaminodiphenylsulfone. BERTI FA; ZITI LM; PEREGO C; RZEPPA HW; RIECKMANN BH; RAPP OP Rev Bras Leprol; 1952; 20(3-4):197-208. PubMed ID: 13047727 [No Abstract] [Full Text] [Related]
45. Mass treatment of leprosy with D.A.D.P.S. (dapsone). GARRETT AS Lepr Rev; 1951; 22(3-4):47-53. PubMed ID: 14889908 [No Abstract] [Full Text] [Related]
46. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy. Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715 [No Abstract] [Full Text] [Related]
47. Clinical evaluation studies in lepromatous leprosy. 4. 4, Butoxy-4'dimethylaminodiphenyl thiourea (DPT), amodiaquin, and 4-4'diaminodiphenyl sulfone (DDS) 2.5 mgm, and 4 mgm. per kg. of body weight. DOULL JA; RODRIGUEZ JN; TOLENTINO JG; FERNANDEZ JV; GUINTO RS; RIVERA JN; MABALAY MC Int J Lepr; 1961; 29():291-317. PubMed ID: 13887566 [No Abstract] [Full Text] [Related]
48. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]
50. [Results of the treatment of 15 cases of lepromatous leprosy with 4-4'-diaminodiphenylsulfone]. LANGUILLON J Bull Soc Pathol Exot Filiales; 1951; 44(5-6):322-9. PubMed ID: 13066934 [No Abstract] [Full Text] [Related]
51. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants. Malhotra B; Das KD; Tutakne MA; Aggarwal SK Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784 [TBL] [Abstract][Full Text] [Related]
52. [Effect of D-cycloserine on lepromatous leprosy]. FLOCH H; MAILLOUX M Publ Inst Pasteur Guyane Fr Inini; 1958 Jul; 19(449):1-5. PubMed ID: 13628241 [No Abstract] [Full Text] [Related]
53. Advances in leprosy control in the last 100 years. Bechelli LM Int J Lepr Other Mycobact Dis; 1973; 41(3):285-97. PubMed ID: 4591732 [No Abstract] [Full Text] [Related]
54. [Treatment of leprosy with monthly injections of 2.50 g. of diaminodiphenylsulfone]. LAVIRON P; LAURET L; KERBASTARD M; JARDIN G Bull Soc Pathol Exot Filiales; 1955; 48(2):126-8. PubMed ID: 13250362 [No Abstract] [Full Text] [Related]
59. Chronic granulomatosus disease: an attempt to stimulate phagocytic activity. McCrae WM; Raeburn JA Lancet; 1972 Jun; 1(7765):1370-1. PubMed ID: 4113569 [No Abstract] [Full Text] [Related]
60. Sulfoxone sodium (diasone) in the treatment of leprosy; a summary analysis of field reports. KELLERSBERGER ER; RULE W Int J Lepr; 1951; 19(3):265-75. PubMed ID: 14888329 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]